Skip to main content

Advertisement

SpringerLink
Log in

Innovative Perspectives of Integrated Chinese Medicine on H. pylori

  • Review
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Helicobacter pylori (H. pylori) treatment requires the development of more effective therapies, mainly owing to the challenges posed by the bacterial resistance to antibiotics. In China, critically high infection and antibiotic resistance rates have limited the application of classic H. pylori eradication therapies. Consequently, researchers are attempting to find new solutions by drawing from traditional medicine. This article reviews basic scientific and clinical progress in the use of integrated Chinese and Western medicine (IM) to treat H. pylori; describes the conflicting results between in vivo and in vitro studies in this regard; discusses the observed clinical effects of IM, with emphasis on traditional patent medicines; and proposes a role for IM in both the diagnosis and treatment of H. pylori, including the use of tongue manifestation as an early diagnostic method and capitalizing on IM’s direct and indirect methods for enhancing antibiotic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The Team of Collaboration of Helicobacter pylori research in China. Prevalence of Helicobacter pylori infection in China. Modern Dig Interv (Chin) 2010;15:265–270.

    Google Scholar 

  2. Song Z, Zhang J, He L, Chen M, Hou X, Li Z, et al. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Dig Liver Dis 2014;46:1077–1081.

    Article  PubMed  CAS  Google Scholar 

  3. Wang B, Lv ZF, Wang YH, Wang H, Liu XQ, Xie Y, et al. Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. World J Gastroenterol 2014;20:14973–14985.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Wu JY, Liou JM, Graham DY. Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol 2014;8:21–28.

    Article  PubMed  CAS  Google Scholar 

  5. Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pylori. World J Gastroenterol 2014;20:5594–5609.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Liu WZ, Xie Y, Lv H, Cheng H, Zeng ZR, Zhou LY, et al. Fifth Chinese national consensus report on the management of Helicobacter pylori infection. Chin J Dig (Chin) 2017;36:364–378.

    Google Scholar 

  7. Wang XL, Jiao WL, Lu ZS. Preliminary screening of Chinese herbal medicine in inhibiting Helicobacter Pylori. Chin J Integr Tradit West Med (Chin) 1994;14:534–536.

    CAS  Google Scholar 

  8. Lien HM, Wang CY, Chang HY, Huang CL, Peng MT, Sing YT, et al. Bioevaluation of Anisomeles indica extracts and their inhibitory effects on Helicobacter pylori-mediated inflammation. J Ethnopharmacol 2013;145:397–401.

    Article  PubMed  CAS  Google Scholar 

  9. Xie JH, Chen YL, Wu QH, Wu J, Su JY, Cao HY, et al. Gastroprotective and anti-Helicobacter pylori potential of herbal formula Huangzhu Jianwei Recipe: safety and efficacy assessment. BMC Complement Altern Med 2013;13:119.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu W, Liu Y, Zhang XZ, Li N, Cheng H. In vitro bactericidal activity of Jinghua Weikang Capsule and its individual herb Chenopodium ambrosioides L. against antibiotic-resistant Helicobacter pylori. Chin J Integr Med 2013;19:54–57.

    Article  PubMed  CAS  Google Scholar 

  11. Ye H, Liu Y, Li N, Yu J, Cheng H, Li J, et al. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo. World J Gastroenterol 2015;21:4178–4183.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shang X, Tan Q, Liu R, Yu K, Li P, Zhao GP. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion’s Mane mushroom, Hericium erinaceus (higher Basidiomycetes). Int J Med Mushrooms 2013;15:165–174.

    Article  PubMed  Google Scholar 

  13. Zhang XQ, Gu HM, Li XZ, Xu ZN, Chen YS, Li Y. Anti-Helicobacter pylori compounds from the ethanol extracts of Geranium wilfordii. J Ethnopharmacol 2013;147:204–207.

    Article  PubMed  CAS  Google Scholar 

  14. Huang YQ, Huang GR, Wu MH, Tang HY, Huang ZS, Zhou XH, et al. Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance. World J Gastroenterol 2015;21:4225–4231.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Yu XD, Xie JH, Wang YH, Li YC, Mo ZZ, Zheng YF, et al. Selective antibacterial activity of patchouli alcohol against Helicobacter pylori based on inhibition of urease. Phytother Res 2015;29:67–72.

    Article  PubMed  Google Scholar 

  16. Feng J, Wang Y, Mo F, Zhagn S, Guo GM. Chemical constituents from ethyl acetate extracts of cortex dictamni and their anti-Helicobacter pylori activity in vitro. J Mountain Agricult and Biol (Chin) 2013;32:85–88.

    Google Scholar 

  17. Yang XT, Lin YH, Zhang JJ, Guo LK, Ge YL, Wang ZR. Antimicrobial activity against Helicobacter pylori of extracts from Liquorice. J Tongji Univ (Chin) 2013;34:26–30.

    Google Scholar 

  18. Lin J, Huang WW. A systematic review of treating Helicobacter pylori infection with traditional Chinese medicine. World J Gastroenterol 2009;15:4715–4719.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wang TT, Zhang YM, Zhang XZ, Cheng H, Hu FL, Han HX, et al. Jinghuaweikang gelatin pearls plus proton pump inhibitor-based triple regimen in the treatment of chronic atrophic gastritis with Helicobacter pylori infection: a multicenter, randomized, controlled clinical study. Natl Med J China (Chin) 2013;93:3491–3495.

    Google Scholar 

  20. Hu FL, Cheng H, Zhang XZ, An HJ, Sheng JQ, Lu NH, et al. Jinghua Weikang Capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study. Natl Med J China (Chin) 2012;92:679–684.

    Google Scholar 

  21. Zhang YM, Wang TT, Ye H, Zhang XZ, Cheng H, Li JX, et al. Jinghua Weikang Capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis: a multicenter, randomized, controlled clinical study. Chin J Integr Tradit West Med Dig (Chin) 2013;21:587–590.

    Google Scholar 

  22. Wenweishu/Yangweishu in the Treatment of Helicobacter pylori Positive Patients with Chronic Gastritis and Peptic Ulcer Study Group. A multicenter study of Chinese patent medicine Wenweishu/Yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer. Natl Med J China (Chin) 2010;90:75–78.

    Google Scholar 

  23. Zhang JB, Zhao XD, Su Q, Liu Y, Gao SB, Liu DS, et al. Effect observation of Dongfangweiyao Capsule in treatment of Helicobacter pylori-associated gastritis. Med Pharm J Chin PLA (Chin) 2013;25:15–17.

    Google Scholar 

  24. Bai M, Kang F, Wang HL. Clinical observation on combination of traditional Chinese and Western medicine treatment of peptic ulcer. China J Chin Med (Chin) 2014;29:1220–1221.

    Google Scholar 

  25. Bharath TS, Reddy MS, Dhanapal R, Raj Kumar NG, Neeladri Raju P, Saraswathi T. Molecular detection and corelation of Helicobacter pylori in dental plaque and gastric biopsies of dyspeptic patients. J Oral Maxillofac Pathol 2014;18:19–24.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zaric S, Bojic B, Popovic B, Milasin J. Eradication of gastric Helicobacter pylori ameliorates halitosis and tongue coating. J Contemp Dent Pract 2015;16:205–209.

    Article  PubMed  Google Scholar 

  27. Wang HH, Pan CH, Wu PP, Luo SF, Lin HJ, Wu CH. Alteration of the tongue manifestation reflects clinical outcomes of peptic ulcer disease. Altern Complement Med 2012;18:1038–1044.

    Article  Google Scholar 

  28. Xie CE, Xue XX, Liu J, Han HX, Meng J, Zhang C. Analysis of relations between syndrome differentiation of Chinese medicine and tongue manifestation, Helicobacter pylori infection of epigastralgia. Chin J Tradit Chin Med Pharm (Chin) 2013;28:2287–2289.

    Google Scholar 

  29. Chen Y, Liu QY, Ye H, Zhang XZ, Cheng H, Xie SS, et al. Multicenter study on evolvement law of traditional Chinese medicine syndromes and syndrome factors of Helicobacter pylori related gastropathy. Modern China Clin Med (Chin) 2015;22:12–16.

    CAS  Google Scholar 

  30. De Francesco V, Zullo A, Perna F, Giorgio F, Hassan C, Vannella L, et al. Helicobacter pylori antibiotic resistance and [13C]urea breath test values. J Med Microbiol 2010;59:588–591.

    Article  PubMed  Google Scholar 

  31. Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 2016;65:9–18.

    Article  PubMed  CAS  Google Scholar 

  32. Feng SL, Zhao DM, Wang WL. The experience and reflection of the pre-treatment of Jinghua Weikang Capsules combined probiotics on Helicobacter pylori. World Chin Med (Chin) 2015;10 supple:18–20

    Google Scholar 

  33. Patel A, Shah N, Prajapati JB. Clinical application of probiotics in the treatment of Helicobacter pylori infection—a brief review. J Microbiol Immunol Infect 2014;47:429–437.

    Article  PubMed  Google Scholar 

  34. Ao MY, Wang MJ, Jiang SY, Xiong SQ, Li ZX, Wu QL, et al. Research progress on the effect of Chinese herbal medicine on intestinal probiotics. Chin J Microecol (Chin) 2011;23:475–478.

    Google Scholar 

  35. Houben MH, van de Beek D, Hensen EF, de Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047–1055.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Traditional Chinese Medicine and Integrated Chinese Medicine, Peking University First Hospital, Beijing, 100034, China

    Hui Ye, Zong-ming Shi, Jing Yu & Xue-zhi Zhang

  2. Department of Traditional Chinese Medicine, Peking University International Hospital, Beijing, 102206, China

    Yao Chen

Authors
  1. Hui Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zong-ming Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xue-zhi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xue-zhi Zhang.

Additional information

Supported by the National Natural Science Foundation of China (No. 81473474), and Beijing Natural Science Foundation (No. 7172220)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, H., Shi, Zm., Chen, Y. et al. Innovative Perspectives of Integrated Chinese Medicine on H. pylori. Chin. J. Integr. Med. 24, 873–880 (2018). https://doi.org/10.1007/s11655-017-2934-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-017-2934-6

Keywords

Search

Navigation